| 英文别名 |
(+-)-sulpiride;SULPIRIDE;5-(aminosufonyl)-n-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide;N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide;(RS)-(+/-)-SULPIRIDE;(RS)-(+/-)-5-AMINOSULFONYL-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-2-METHOXYBENZAMIDE;(+/-)-SULPIRIDE;(+/-)-N-1-(ETHYLPYRROLIDIN-2-YLMETHYL)-2-METHOXY-5-SULFAMOYLBENZAMIDE;Abilit;Aiglonyl;(±)-Sulpiride;(RS)-(±)-Sulpiride;rac Sulpiride;-]-N-1-[ETHYLPYRROLIDIN-2-YLMETHYL]-2-METHOXY-5-SULFAMOYLBENZAMIDE;(±)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide;Sulpyrid;Sulpirid;Dolmatil;Dogmatil;Dobren;Guastil;Misulvan;Sursumid;Mirbanil;Eglonyl;Omperan;Splotin;Neogama;Miradol;Meresa;Pyrkappl;Coolspan;Sernevin;Dogmatyl;Psicocen;Calmoflorine;Sulpitil;Ozoderpin;Norestran;Mariastel;Eusulpid;Desmenat;Sulpirida;Championyl;Zemorcon;Stamonevrol;Lisopiride;Isnamide;Darleton;Alimoral;Sulpiridum;Kylistro;Fardalan;Nufarol;Enimon;Fidelan;Equilid;Suprium;Omiryl;Normum;Eglonil;Valirem;Restful;Sulpiride;A809768;AC-12181;MFCD00055061;SULPIRIDE,(+);DivK1c_000278;(y)-Sulpiride;Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-;5-22-08-00105 (Beilstein Handbook Reference);SULPIRIDE (EP IMPURITY);dl-sulpiride;Sulpiridum (INN-Latin);STR09321;BDBM11638;HMS3371P16;HMS3411D18;(.+/-.)-Sulpiride;NCGC00015966-16;HMS2095K13;N-(1-ETHYL-2-PYRROLIDINYLMETHYL)-2-METHOXY-5-SULFAMIDOBENZAMIDE;(?)-Sulpiride;SDCCGSBI-0051020.P002;RD 1403;NCGC00015966-07;NCGC00261735-01;Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-;AKOS004912732;NCGC00024852-04;( inverted question mark)-Sulpiride;(RS)-(+/-)-5-Aminosulfonyl-N-[(1-ethyl -2-pyrrolidinyl)methyl]-2-methoxybenzamide;Sulpiride (JP17/USAN/INN);BPBio1_001255;SCHEMBL8421;LP01050;Q422418;RD-1403;N-(1-Ethyl-pyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoyl-benzamide;NCGC00015966-06;Levosulpiridum [INN-Latin];SR-01000075402-6;PS30 - Sulpiride;CCG-205127;MLS001306443;Z84655412;NSC 757850;Sulpiride, European Pharmacopoeia (EP) Reference Standard;Sulpor;S 8010;Prestwick2_000056;IDI1_000278;HMS3651G12;SULPIRIDE (EP MONOGRAPH);Prestwick3_000056;(+/-)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide;5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide;DTXSID1042574;HMS3266P12;FT-0652244;HMS3372O01;HY-B1019;Prestwick1_000056;Magnetic resonance imaging sulpiride;SR-01000075402;15676-16-1;SMR000038923;Lopac0_001050;NCGC00024852-05;NCGC00024852-03;DTXCID9022574;BCP04500;R. D. 1403;1-ethyl-2-(2-methoxy-5-sulfamoylbenzamidomethyl)pyrrolidine;N-(1-Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide;NCGC00024852-02;NS00010476;BRD-A55272860-001-03-9;HMS3263A22;Levosulpirida [INN-Spanish];FT-0674703;Sulpiride 1.0 mg/ml in Methanol;CHEBI:32168;SULPIRIDE [USAN];SULPIRIDE (MART.);D01226;BRN 0494008;(plusmn)-sulpiride;Biomol-NT_000037;(+)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2... |
